Lung cancer therapy using genetically modified macrophages
Lung cancer therapy using genetically modified macrophages
批准号:
488420
负责人:
Post Martin
金额:
$71.33万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2023
资助国家:
加拿大
项目状态:
未结题
起止时间:
2023-09-01 至 2028-09-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Lung cancer remains the leading cause of cancer death worldwide. Current therapies have not been effective in curbing this death rate. New therapies are urgently needed. We have created special lung immune cells in the lab from stem cells that are designe
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Lung Development, Injury and Repair
-
批准号:312099
-
项目类别:Operating Grants
-
资助金额:$172.95万
-
财政年份:2014
-
负责人:Post Martin
-
依托单位:
CRC Tier 1
-
批准号:314139
-
项目类别:
-
资助金额:$101.99万
-
财政年份:2013
-
负责人:Post Martin
-
依托单位:
Effect of mechanical forces on lung development
-
批准号:252199
-
项目类别:Operating Grants
-
资助金额:$52.2万
-
财政年份:2012
-
负责人:Post Martin
-
依托单位:
Epithelial-mesenchymal (endothelial)interactions regulate postnatal lung development
-
批准号:200408
-
项目类别:Operating Grants
-
资助金额:$57.72万
-
财政年份:2010
-
负责人:Post Martin
-
依托单位: